Isolation, synthesis and structures of cytotoxic ginsenoside derivatives

Molecules

Volumn 12, Issue 9, 2007, Pages 2140-2150

  Lei, Jun ^a   Li, Xiang ^a   Gong, Xiao Jie ^b   Zheng, Yi Nan ^a  

^a JILIN AGRICULTURAL UNIVERSITY   (China)

^b DALIAN UNIVERSITY   (China)

Author keywords

Ginsenoside DM1; Ginsenoside PM1; Ginsenoside SM1; Isolation; Synthesis

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON; CYTOTOXIN; ESTER; GINSENOSIDE;

ARTICLE; CHEMISTRY; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARBON ISOTOPES; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOTOXINS; DRUG SCREENING ASSAYS, ANTITUMOR; ESTERS; GINSENOSIDES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 34848923600     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/12092140     Document Type: Article

References (23)

1. Ligor, T.; Ludwiczuk, A.; Wolski, T.; Buszewski, B. Isolation and determination of ginsenosides in American ginseng leaves and root extracts by LC-MS. Anal. Bioanal. Chem. 2005, 383, 1098-1105.
2. Liu, W.; Xu, S.; Che, C. Anti-proliferative efect of ginseng saponins on human prostate cancer cell line, Life Sci. 2000, 67, 1297-130.
3. WAF1 in human hepotoma SK-HEP-1 cells. Eur. J. Cancer 1999, 35, 507-511.
4. Lee, K.; Lee, Y.; Kim, S.; Park, J.; Lee, S. Ginsenoside-Rg5 suppresses cyclin E-dependent protein kinase activity via up-regulation of p21 Cip/WAF1 and down-regulating cyclin E in SK-HEP-1 cells. Anticancer Res. 1997, 17, 1067-1072.
5. Lee, Y.; Lee H.; Lee, Y.; Chung, H.; Kim, S.; Lee, S.; Park, B.; Kim, K. Involvement of glucocorticoid receptor in the induction of differentiation by ginsenoside in F9 teratocarcinoma cells, J Steroid Biochem. Mol. Biol. 1998, 67, 105-111.
6. Cho, W.; Chung, W.; Lee, S.; Leung, A.; Cheng C.; Yue K. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 2006, 550, 173-179.
7. Lee W.; Kao S.; Liu I.; Cheng J. Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats. Horm. Metab. Res. 2007, 39, 347-354.
8. Akao, T.; Kida, H.; Kanaoka, M.; Hattori, M.; Kobashi, K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 1998, 50, 1155-1160.
9. Wakabayashi, C.; Hasegawa, H.; Murata, J.; Saiki I. In vivo anti-metastatic action of ginseng proto-panaxadiol saponins is based on their intestinal metabolites after oral administration. Oncol. Res. 1997, 9, 411-417.
10. Wakabayashi, C.; Hasegawa, H.; Murata, J. The expression of in vivo anti-metastatic effect of ginseng protopanaxadiol saponins is mediated by their intestinal metabolites after oral administration. J. Trad. Med. 1997, 14, 180-185.
11. Hasegawa, H.; Sung, J.; Huh, J. Ginseng intestinal bacterial metabolite IH901 as a new anti-metastatic agent. Arch. Pharm. Res. 1997, 20, 539-544.
12. Hasegawa H. Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with Fatty Acid. J. Pharmacol. Sci. 2004, 95, 153-157.
13. Tawab, M.; Bahr, U.; Karas, M.; Wurglics, M. Degeneration of ginsenosides in humans after oral administration. Drug Metab. Dispos. 2003, 31, 1065-1071.
14. Lee, J.; Shin J.; Chun, K.; Park, K.; Chung, W.; Bang, Y.; Sung, J.; Surh, Y. Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol-type ginsenosides in mouse skin. Carcinogenesis 2005, 26, 359-367.
15. Hasegawa, H.; Lee, K.; Nagaoka, T.; Tezuka, Y.; Uchiyama, M.; Kadota, S.; Saiki, I. Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatty acid esters. Biol. Pharm. Bull. 2000, 23, 298-304.
16. Li, X.; Li, X.; Lei, J. Studies on chemical components and their pharmacological activities of Panax ginseng root. Drug Discovery and Traditional Chinese Medicine: Science, Regulation, and Globalization; Kluwer Academic Publishers: Maryland, 2000; pp. 95-109.
17. 3, a new triterpenoid saponin from the fruits of Panax ginseng C. A. Mey. J. Asian Nat. Prod. Res. 2004, 6, 289-293.
18. Sun, G.; Liu, Z.; Li, X.; Zheng, Y.; Wang, J. Isolation and identification of two malonyl-ginsenosides from the fresh root of Panax Ginseng. Chin. J. Anal. Chem. 2005, 33, 1783-1786.
19. Gong X. Study on chemical modification of the enzyme of the enzyme metabolites and its antitumor activities, PHD dissertation of Jilin Agricultural University, 2004, 96-103.
20. 3 in a human bladder carcinoma cell line. Chin. J. Clin. Oncol. 2006, 4, 283-287.
21. Cheng, C.; Yang, S.; Huang, C.; Chen, J.; Chang, W.; Hsu, S. Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother. Pharmacol. 2005, 55, 531-540.
22. Connolly, T.; Carruthers, A.; Melchior D. Effects of bilayer cholesterol on human erythrocyte hexose transport protein activity in synthetic lecithin bilayers. Biochemistry 1985, 24, 2865-2873.
23. Baruch, B.; Lina W.; Einat, B.; Jardena, N.; Jacob, S.; Haim, G.; Eyal, F. Variable cytotoxicity of amifostine in malignant and non-malignant cell lines. Oncol. Rep. 2003, 10, 1609-1613.